Montelukast combined inhaled budesonide in moderate to severe asthma in children Efficacy.doc

 PAGE \* MERGEFORMAT 10 Montelukast combined inhaled budesonide in moderate to severe asthma in children Efficacy [Abstract] Objective: Cha Menglu Special Joint Secretary budesonide inhalation therapy in children with moderate to severe asthma patients. Methods: 45 patients with moderate to severe asthmatic children were in non-acute phase, 20 patients observed by the United montelukast budesonide aerosol (100 ~ 200 g / d), control group 25 cases of budesonide aerosol (400 ~ 600 g / d, for more than 3 months of treatment. records of children with asthma symptoms score, and on-demand episodes of acute inhalation of 2 agonists number available. Results: The group rate of asthma during the day and night rates, and on-demand episodes of acute 2 agonist inhalation spray, respectively (0.1 + - 0.31 points (0.15 + -0.37 points (0.2 + -0.37 times (0.75 + -0.64 spray, while the control group were (1.52 + -0.87 points (1.56 + -0.77 points (1.84 + -1.28 times (2.68 + -1.11 spray, two groups were significantly (P lt;0.01. Conclusion: Oral montelukast combined inhaled budesonide in children can significantly improve the clinical efficacy of moderate to severe asthma. [Keywords:] montelukast, budesonide, children, asthma Therapeutic Effects of Montelukast Combined with Abstract] Objective: To observe the clinical effect of montelukast combined budesonide inhalation therapy on children with moderate to severe asthma.Methods: Forty five cases of children with moderate to severe asthma weren’t in acute episode period, the observation group of 20 cases received montelukast combined with budesonide (inhalation aerosol 100 ~ 200 g / d), while the control group of 25 cases only budesonide (inhalation aerosol 400 ~ 600 g / d), for more than 3 months of treatment. Records of asthma symptom score, acute attack frequency and demand for quick 2 agonist inhalation were made. Results: Of the observation group daytime asthma score, night time score, acute attack frequency and dema